(KOD) - Management Comments

(KOD) – Management Comments

Nov 16, 2020 06:53 AM Kodiak Sciences Inc. (KOD) Reports Complete Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration
Oct 5, 2020 09:09 AM Kodiak Sciences Inc. (KOD) Reports First Patient Treatment in Three Ph. 3 Studies of KSI-301
Aug 10, 2020 05:54 AM
Jul 10, 2020 04:02 PM
Apr 2, 2020 04:10 PM
Feb 10, 2020 06:16 AM
Dec 19, 2019 04:01 PM
Dec 2, 2019 06:08 AM
Sep 16, 2019 05:58 AM
Aug 14, 2019 05:50 AM
Jul 29, 2019 05:48 AM
Dec 21, 2018 06:03 AM